Haemonetics
285 hedge funds and large institutions have $4.44B invested in Haemonetics in 2020 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 103 increasing their positions, 97 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
12% less capital invested
Capital invested by funds: $5.05B → $4.44B (-$610M)
60% less call options, than puts
Call options by funds: $11.6M | Put options by funds: $29.1M
80% less funds holding in top 10
Funds holding in top 10: 5 → 1 (-4)
Holders
285
Holding in Top 10
1
Calls
$11.6M
Puts
$29.1M
Top Buyers
| 1 | +$98M | |
| 2 | +$44.8M | |
| 3 | +$39.6M | |
| 4 |
Morgan Stanley
New York
|
+$35.3M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$32.4M |
Top Sellers
| 1 | -$143M | |
| 2 | -$84.4M | |
| 3 | -$78.6M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$63.9M |
| 5 |
Goldman Sachs
New York
|
-$59.3M |